Costco stock price steadies after hours as tariff threat rattles markets
21 January 2026

Costco stock price steadies after hours as tariff threat rattles markets

New York, January 20, 2026, 18:23 EST — After-hours

  • Costco shares saw little movement in after-hours trading following a volatile session.
  • A fresh tariff shock sparked a broad selloff, sending volatility up.
  • Two directors at Costco reported minor insider trades in their SEC filings.

Costco Wholesale Corporation shares ticked up 0.1% to $964.26 in after-hours trading Tuesday. The stock swung between $954.23 and $969.86 during the session, with roughly 3.2 million shares changing hands.

Costco remained steady as Wall Street suffered its largest one-day drop in three months. The S&P 500 slipped 2.06%, while the Nasdaq fell 2.39%. The sell-off followed President Donald Trump’s threat of new tariffs on eight European countries, starting at 10% on Feb. 1 and potentially rising to 25% on June 1 if the U.S. doesn’t secure control of Greenland. The CBOE Volatility Index closed at 20.09, its highest since Nov. 24. Jamie Cox, managing partner at Harris Financial Group, said he’d “be surprised” if this tariff spat triggers a 3% to 5% drop this week. Reuters

Costco held firm amid retail dips. Walmart dropped 0.8%, Target fell 1.7%, and BJ’s Wholesale slid 1.3% in late trading. The SPDR S&P Retail ETF declined 1.8% over the same period.

Costco often acts as a defensive play when markets get shaky, buoyed by steady membership fees and a value-driven model that attracts shoppers even in downturns. The retailer topped earnings and sales forecasts in its December quarter, citing robust holiday season demand.

A filing posted Tuesday revealed director Susan L. Decker sold 458 shares at $955 each on Jan. 16, trimming her stake to 8,531.936 shares. Form 4 is the SEC disclosure insiders must file after stock transactions.

A separate Form 4 revealed director Gina Marie Raimondo was granted 215 restricted stock units, set to vest in thirds beginning October 2026, according to the filing.

Costco announced last week a quarterly dividend of $1.30 per share, payable on Feb. 13 to shareholders recorded by Jan. 30. The retailer currently runs 923 warehouses worldwide.

On Jan. 7, the retailer reported December net sales of $29.86 billion for the five weeks ending Jan. 4, marking an 8.5% increase from the previous year. Comparable sales, which track stores open at least a year, climbed 7.0% over the period. Its “digitally enabled” comparable sales surged 18.9%, the company said. Costco Investor Relations

Costco isn’t off the hook if the tariff dispute escalates. Rising import expenses could tighten margins throughout retail supply chains, and a widespread drop in consumer spending would challenge the club’s business model.

Mark your calendars for March 5. That’s when Costco will release its fiscal second-quarter results and hold its earnings call at 2 p.m. PT.

Khadija Saeed

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors. Follow Khadija Saeed on Google News.

AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

Taiwan Semiconductor

NYSE: TSM 96 / 100
#2 BUY

AerCap

NYSE: AER 95 / 100
#3 BUY ON PULLBACK

Constellation Energy

NASDAQ: CEG 93 / 100
#4 BUY

Walt Disney

NYSE: DIS 90 / 100
#5 ACCUMULATE

American International Group

NYSE: AIG 87 / 100
View full portfolio
Editorial model selection. Not personalised advice.
GE Aerospace stock slides nearly 4% as tariff jitters hit Wall Street ahead of earnings
Previous Story

GE Aerospace stock slides nearly 4% as tariff jitters hit Wall Street ahead of earnings

Eli Lilly stock ticks up after FDA “breakthrough” tag for ovarian cancer drug
Next Story

Eli Lilly stock ticks up after FDA “breakthrough” tag for ovarian cancer drug